Finally, we integrated proteomic data from BLISS and performed in-depth pathway and tissue enrichment analyses using MAGMA and GSA-MiXeR.<h4>Results</h4>Our multi-pronged approach identified two novel susceptibility genes associated with GDM risk: <i>ELL2</i> and <i>ATRAID</i>. The gene discussed is ELL2; the disease is gestational diabetes.